搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
Trinity Biotech Reports Q3 2024 Financial Performance
Trinity Biotech ( (TRIB) ) has released its Q3 earnings. Here is a breakdown of the information Trinity Biotech presented to its ...
FoodNavigator-Asia
5 小时
High dietary intake of magnesium and fibre mitigates risk of metabolic syndrome among ...
MetS is a group of metabolic abnormalities, including obesity, hypertension and impaired glucose metabolism, that together ...
10 小时
13 'Healthy' Restaurant Salads That Are Loaded with Calories
Are restaurant salads sabotaging your diet? Discover the surprising calorie content of popular high-calorie restaurant salads ...
13 小时
Amgen Sells Off: Keep Calm And Buy The Dip
Analyzing Amgen's stock drop, management's response, and potential for growth in GLP-1 candidate MariTide in a volatile ...
15 小时
How you can make small changes and keep your post-turkey pie on the menu this Thanksgiving
Thanksgiving is almost here and it's the kick-off to a season full of food, stress, unhealthy habits and, of course, more ...
19 小时
Samsung Bioepis, Biogen Get European Commission Approval For Opuviz, A Biosimilar To ...
(RTTNews) - Samsung Bioepis Co., Ltd. and Biogen Inc. (BIIB) Monday announced that the European Commission (EC) has approved Opuviz, a biosimilar to Regeneron Pharmaceuticals' Aflibercept.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈